Xenetic Biosciences XBIO Stock
Xenetic Biosciences Price Chart
Xenetic Biosciences XBIO Financial and Trading Overview
| Xenetic Biosciences stock price | 2.79 USD |
| Previous Close | 3.19 USD |
| Open | 3.29 USD |
| Bid | 0 USD x 1400 |
| Ask | 0 USD x 900 |
| Day's Range | 3.02 - 3.31 USD |
| 52 Week Range | 2.4 - 10 USD |
| Volume | 6.11K USD |
| Avg. Volume | 24.29K USD |
| Market Cap | 4.84M USD |
| Beta (5Y Monthly) | 2.794718 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.57 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 40 USD |
XBIO Valuation Measures
| Enterprise Value | -7153907 USD |
| Trailing P/E | N/A |
| Forward P/E | -3.6666667 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.5149212 |
| Price/Book (mrq) | 0.37631238 |
| Enterprise Value/Revenue | -3.719 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Xenetic Biosciences Stock Price History
| Beta (5Y Monthly) | 2.794718 |
| 52-Week Change | -52.45% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10 USD |
| 52 Week Low | 2.4 USD |
| 50-Day Moving Average | 3.8 USD |
| 200-Day Moving Average | 4.65 USD |
XBIO Share Statistics
| Avg. Volume (3 month) | 24.29K USD |
| Avg. Daily Volume (10-Days) | 10.94K USD |
| Shares Outstanding | 1.52M |
| Float | 1.31M |
| Short Ratio | 0.51 |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | 30.99K |
| Short % of Float | 2.06% |
| Short % of Shares Outstanding | 2.03% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -312.58% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.71% |
| Return on Equity (ttm) | -39.055% |
Income Statement
| Revenue (ttm) | 1.92M USD |
| Revenue Per Share (ttm) | 1.31 USD |
| Quarterly Revenue Growth (yoy) | 55.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -5815296 USD |
| Diluted EPS (ttm) | -4 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 11.99M USD |
| Total Cash Per Share (mrq) | 7.91 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 15.03 |
| Book Value Per Share (mrq) | 8.477 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3661512 USD |
| Levered Free Cash Flow (ttm) | -4113556 USD |
Profile of Xenetic Biosciences
| Country | United States |
| State | MA |
| City | Framingham |
| Address | 945 Concord Street |
| ZIP | 01701 |
| Phone | 781 778 7720 |
| Website | https://www.xeneticbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
Q&A For Xenetic Biosciences Stock
What is a current XBIO stock price?
Xenetic Biosciences XBIO stock price today per share is 2.79 USD.
How to purchase Xenetic Biosciences stock?
You can buy XBIO shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Xenetic Biosciences?
The stock symbol or ticker of Xenetic Biosciences is XBIO.
Which industry does the Xenetic Biosciences company belong to?
The Xenetic Biosciences industry is Biotechnology.
How many shares does Xenetic Biosciences have in circulation?
The max supply of Xenetic Biosciences shares is 1.54M.
What is Xenetic Biosciences Price to Earnings Ratio (PE Ratio)?
Xenetic Biosciences PE Ratio is now.
What was Xenetic Biosciences earnings per share over the trailing 12 months (TTM)?
Xenetic Biosciences EPS is -2.57 USD over the trailing 12 months.
Which sector does the Xenetic Biosciences company belong to?
The Xenetic Biosciences sector is Healthcare.
Xenetic Biosciences XBIO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Capital Market Composite RCMP | 102.15 USD — |
-0.54
|
— — | 101.35 USD — | 102.39 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}